These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption. Tao H, Okamoto M, Nishikawa M, Yoshikawa H, Myoui A. PLoS One; 2011 Mar; 6(8):e23199. PubMed ID: 21886782 [Abstract] [Full Text] [Related]
6. [The effect of ferric ion on the differentiation of osteoclast and bone resorption]. Jia P, He YF, Gao C, Du HB, Hu ZY, Feng XQ, Li BY, Zhang ZL, Xu YJ, Lin H. Zhonghua Yi Xue Za Zhi; 2012 Aug 21; 92(31):2214-8. PubMed ID: 23158430 [Abstract] [Full Text] [Related]
10. Ethanol extract of Cyathulae Radix inhibits osteoclast differentiation and bone loss. Shi L, Ren L, Li J, Liu X, Lu J, Jia L, Xie B, Tang S, Liu W, Zhang J. Chin J Nat Med; 2024 Mar 01; 22(3):212-223. PubMed ID: 38553189 [Abstract] [Full Text] [Related]
14. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα. Ma Z, Yu R, Zhao J, Sun L, Jian L, Li C, Liu X. Inflamm Res; 2019 Feb 01; 68(2):157-166. PubMed ID: 30604211 [Abstract] [Full Text] [Related]
16. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption. Kim MS, Day CJ, Selinger CI, Magno CL, Stephens SR, Morrison NA. J Biol Chem; 2006 Jan 13; 281(2):1274-85. PubMed ID: 16280328 [Abstract] [Full Text] [Related]